|
| Exchange Disseminated Time 21/10/2016 19:20:32 | With reference to the earlier letter dated July 27, 2016, regarding agreement entered with RPG Life Sciences Ltd to divest seven prescription brands in India, owned by Sun Pharmaceutical Industries Limited and its subsidiary.
Further to the above, Sun Pharmaceutical Industries Ltd has now informed BSE that the Company have received the approval of the Competition Commission of India and all the necessary formalities for Closure of the said transaction have been completed and the aforesaid transaction has been successfully closed today i.e. October 21, 2016. |
|
|